Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011849 (
diabetes
)
277,896
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cyclic AMP, glucose and cortisol in plasma were measured in three groups of patients undergoing hysterectomy. The operations were performed under general anaesthesia, under general anaesthesia combined with epidural
analgesia
and under epidural
analgesia
alone. Surgery elicited a significant rise in plasma cyclic AMP, glucose and cortisol when performed under general anaesthesia alone. Epidural
analgesia
extending from T4-6 to S5 combined with general anaesthesia abolished the rise in cyclic AMP and reduced the increase in glucose and cortisol and epidural
analgesia
alone extending from T4 to S5 blocked the rise in glucose and cortisol as well as that in cyclic AMP. The results support the theory that afferent nerve impulses from the area of trauma are of major importance for the catabolic state induced by surgical procedures and indicate that anaesthetic management which includes blockade of afferent nerve impulses which includes blockade of afferent nerve impulses from the area of trauma can be reduce the catabolic response to surgery. These observations could be of value in the operative management of patients with
diabetes mellitus
and possibly in other groups by patients with a high surgical morbidity.
...
PMID:Inhibition of plasma cyclic AMP, glucose and cortisol response to surgery by epidural analgesia. 20 31
A postal inquiry into the current use of subarachnoid spinal
analgesia
obtained replies from approximately 70% of consultants in both Scotland and Sweden. Although medico-legal anxiety was still an important feature of Scottish practice, the publication of large series with a low incidence of complications had also exerted some influence, and 40% of consultants employed the technique. In contrast, 70% of Swedish replies indicated current use of spinal
analgesia
and the individual frequency of administration was considerably higher. The present popularity of epidural
analgesia
has contributed to some decline in the use of subarachnoid spinal
analgesia
in Sweden, particularly in the case of longer surgical procedures. Anaesthetists in both countries expressed dissatisfaction with the limited choice of available spinal agents and considered their duration of action to be inadequate. In Scotland, conditional indications, such as
diabetes mellitus
and respiratory disease, were of major importance, whereas Swedish users more often specified surgical procedures for which subarachnoid spinal
analgesia
was considered to be the anaesthetic of choice. Few anaesthetists had experience of complications and no major neurological sequelae were reported. More than 80% of replies indicated that subarachnoid spinal anaesthesia had a useful place in anaesthetic practice.
...
PMID:Subarachnoid spinal analgesia. A comparative survey of current practice in Scotland and Sweden. 72 13
Anaerobic necrotizing soft tissue infections are known for their devastating effects of tissue destruction and death. These infections may occur as a result of trauma, surgical intervention or occur spontaneously in predisposed individuals. They are caused by a wide range of anaerobic organisms and may be categorised according to the tissue involvement as Necrotizing Fasciitis and Myonecrosis. A five year review of patients admitted for hyperbaric oxygen (HBO) therapy and requiring intensive care revealed a patient group numbering 25, roughly equally divided between the two classifications of tissue involvement. Trauma was an aetiological factor in 5 of these cases. Cancer and
diabetes mellitus
were also prominent aetiological factors. Treatment consisted of the triad of early selective/aggressive surgery, high dose antibiotic therapy and HBO therapy. The mortality of the group was 25%. Delay in treatment was associated with increased mortality. Nursing care, for this particular patient group is demanding, requiring particular attention to wound care,
analgesia
, transport, psychosocial care of patient with mutilating wounds, nutrition and temperature homeostasis. It is a cause for concern that two cases occurred after elective orthopaedic procedures requiring the application of plaster of paris (POP) cast over a leg.
...
PMID:A five year review of anaerobic, necrotizing soft tissue infections: a nursing perspective. 129 Aug 88
To investigate the possible mechanisms of the alterations in morphine-induced
analgesia
observed in diabetic mice, we examined the influence of streptozotocin-induced (STZ-induced)
diabetes
on
analgesia
mediated by the different opioid receptors. The antinociceptive potency of morphine (10 mg/kg), administered s.c., as determined by both the tail-pinch and the tail-flick test, was significantly reduced in diabetic mice as compared to that in controls. Mice with STZ-induced
diabetes
had significantly decreased sensitivity to intracerebroventricularly (i.c.v.) administered mu-opioid agonists, such as morphine (10 micrograms) and [D-Ala2,N-Me Phe4,Gly-ol5]enkephalin (DAMGO, 0.5 micrograms). However, i.c.v. administration of [D-Pen2,5]enkephalin (DPDPE, 5 micrograms), a delta-opioid agonist, and U-50,488H (50 micrograms), a kappa-opioid agonist, produced pronounced antinociception in both control and diabetic mice. Furthermore, there were no significant differences in antinociceptive potency between diabetic and control mice when morphine (1 microgram), DAMGO (10 micrograms), DPDPE (0.5 micrograms) or U-50,488H (50 micrograms) was administered intrathecally. In conclusion, mice with STZ-induced
diabetes
are selectively hyporesponsive to supraspinal mu-opioid receptor-mediated antinociception, but they are normally responsive to activation of delta- and kappa-opioid receptors.
...
PMID:Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists. 131 65
We evaluated the effects of s.c. administration of naloxone in mice with streptozotocin-induced
diabetes
, compared to those in age-matched naive mice. Naloxone injected s.c. produced a dose-related increase in tail-flick latency in diabetic mice but not in naive mice. Naloxone-induced
analgesia
in diabetic mice was significantly reduced by pretreatment with naltrindole, a selective antagonist of delta-opioid receptors. These results indicate that naloxone-induced 'paradoxical'
analgesia
in diabetic mice may be mediated by delta-opioid receptors.
...
PMID:Naloxone-induced analgesia in diabetic mice. 131 38
The present studies were designed to determine whether streptozotocin-induced (STZ-induced)
diabetes
in mice can attenuate the development of antinociception induced by exposure to both foot shock and forced swimming stress. Foot shock stress produced significant
analgesia
both in control and diabetic mice. However, the extent of foot shock stress-induced
analgesia
(FSSIA) in diabetic mice was significantly lower than that in control mice. Naloxone (2 mg/kg, i.p.) significantly attenuated FSSIA in control mice, but was without effect on FSSIA in diabetic mice. One-minute swimming stress had no significant effect on tail-pinch latency in control mice, whereas 3-min swimming stress produced significant
analgesia
in these mice. Diabetic mice exhibited robust swimming stress-induced
analgesia
(SSIA): one-min swimming stress produced significant
analgesia
in diabetic mice. These analgesic effects were blocked by naltrindole, a selective antagonist of delta-opioid receptors, but not by pretreatment with beta-funaltrexamine, an irreversible and selective antagonist of mu-opioid receptors. These results suggest that the deficiency in the functioning of mu-opioid receptors caused by
diabetes
results in significant activation of an endogenous analgesic system, which is mediated mainly by delta-opioid receptors.
...
PMID:Effects of diabetes on stress-induced analgesia in mice. 132 87
The effect of
diabetes
on periaqueductal gray matter (PAG) stimulation-produced
analgesia
(SPA) was examined in rats. PAG SPA was assessed using the tail-pinch test. PAG stimulation produced marked
analgesia
in both naive and diabetic rats. Furthermore, the degree of PAG SPA did not differ between naive and diabetic rats. PAG SPA was significantly attenuated by a low dose (0.5 mg/kg, s.c.) of naloxone in naive rats, but not in diabetic rats. However, a high dose (5 mg/kg, s.c.) of naloxone significantly and equally attenuated PAG SPA in both naive and diabetic rats. On the other hand, the analgesic potency of morphine (3 mg/kg, s.c.) was significantly reduced in diabetic rats as compared with naive rats. These results suggest that PAG SPA in diabetic rats may be mediated by different opioid receptor interactions as compared with naive rats.
...
PMID:Periaqueductal gray matter stimulation-produced analgesia in diabetic rats. 140 10
The effects of naloxone on the analgesic response were examined using the tail-flick test, in mice with streptozotocin-induced
diabetes
. Subcutaneous injection of naloxone (5 mg/kg, s.c.) produced a marked
analgesia
in diabetic mice but not in age-matched non-diabetic mice. Naloxone-induced
analgesia
in diabetic mice was significantly reduced by pretreatment with naltrindole (0.1 mg/kg, s.c.), a selective antagonist of delta-opioid receptors. By contrast, no significant naloxone-induced increase in tail-flick latency in diabetic mice was observed after chronic treatment with naloxone (5 mg/kg, s.c.) for 5 days. However, the tail-flick latency was significantly increased by chronic treatment with naloxone in non-diabetic mice. Furthermore, the significant naloxone-induced increase in tail-flick latency in non-diabetic mice that had been chronically treated with naloxone was also antagonized by pretreatment with naltrindole. Chronic pretreatment with 5 mg/kg of naloxone for 5 days markedly attenuated the analgesic effect of the delta-agonist DPDPE in diabetic mice, whereas this pretreatment significantly enhanced the effect of DPDPE in non-diabetic mice. These results suggest that naloxone-induced 'paradoxical'
analgesia
in mice may be mediated predominantly by delta-opioid receptors.
...
PMID:Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of delta-opioid receptors. 145 Sep 2
The didactic lecture deals with four questions: What is the origin of an isolated indolent arthropathy?
diabetes
, amylose, leprosis. What diagnosis in an adult familial form? Thevenard's disease when amylosis has been excluded. What are the varieties of congenital indolent arthropathies? An early recessive form of Thevenard's disease and the congenital
analgesia
. How to deal with a unilateral indolent arthropathy? First of all, look for dysraphism.
...
PMID:[Indolent arthropathies of the lower limbs]. 171 10
A case is presented of a morbidly obese parturient who had multiple medical problems. She had angina and was receiving nitrate therapy, had insulin-dependent
diabetes mellitus
, hypertension, asthma and benign intracranial hypertension (pseudotumour cerebri). Lumbar epidural
analgesia
was chosen for labour and delivery and resulted in an uneventful outcome.
...
PMID:Anaesthetic management of a complex morbidly obese parturient. 174 26
1
2
3
4
5
6
7
8
9
10
Next >>